A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

Pharmacokinetics of YM178Healthy Subjects

Interventions

DRUG

YM178 modified release (OCAS)

oral

DRUG

YM178 immediate release (IR)

oral

Trial Locations (1)

Pharma Bio-Research B.V., Zuidlaren

All Listed Sponsors

lead

Astellas Pharma Europe B.V.

INDUSTRY